Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Active Not Recruiting NCT07788443

V-CAF Technique for Miller Class III Gingival Recession

Conditions: Gingival Recession, Gum Recession

Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Phase: NA
Enrollment: 25
Sponsor: University of Medicine and Pharmacy at Ho Chi Minh City

Location: Faculty of Dentistry, University of Medicine and Pharmacy at Ho Chi Minh City Ho Chi Minh City

Summary

The purpose of this clinical trial is to evaluate the effectiveness of a modified surgical technique called the vertically coronally advanced flap (V-CAF) combined with a connective tissue graft and tissue regeneration for treating gingival recession. For more severe cases (Miller Class III), the study investigates the relationship between the pre-operative Coronally Advanced Flap Difficulty Score (CAFDS) and post-operative outcomes, such as the root coverage rate and interdental papilla height. Participants will undergo the assigned surgical treatment and will be followed up at 3, 6, and 12 months to assess healing and tissue stability.

Eligibility Criteria

Inclusion Criteria: * Patients aged 18 years or older * Systemically healthy (no systemic diseases) and not pregnant * Non-smokers * Presence of at least one tooth presenting with Miller Class III gingival recession with a recession depth of ≥ 2 mm * Medium or thin gingival biotype Exclusion Criteria: * History of periodontal treatment or mucogingival/periodontal surgery at the study site * Presence of fixed prosthesis on the tooth with gingival recession * Teeth with rotation or crowding * Presence of occlusal trauma * Active or progressive periodontitis * Patients who fail to attend follow-up visits or demonstrate non-compliance with post-operative care instructions

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07788443). StuddyBuddy aggregates publicly available trial information.